DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Inversine (Mecamylamine Hydrochloride) - Current Clinical Trials

 
 



Inversine Related Clinical Trials

Study of the Effects of Mecamylamine and Varenicline in Schizophrenia [Completed]

Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders [Completed]

Nicotinic Modulation of the Default Network [Completed]

Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients [Recruiting]

Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence [Completed]

Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder [Completed]

Topical Ocular Mecamylamine in Diabetic Macular Edema (DME) [Completed]

Nicotinic Receptor Augmentation of SSRI Antidepressants [Completed]

Treatment of Orthostatic Intolerance [Active, not recruiting]

Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGF [Completed]

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD) [Terminated]

Combinations of Pharmacologic Smoking Cessation Treatments [Completed]

Nicotinic Modulation of the Default Network of Resting Brain Function [Completed]

Treatment to Quit Smoking [Completed]

Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214 [Completed]

To Investigate Safety, Tolerability and Pharmacokinetics of TC-5214 in Healthy Male Japanese Subjects [Completed]

TC-5214 as add-on the Treatment of Major Depressive Disorder [Completed]

To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function [Completed]

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD) [Completed]

A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder [Completed]

To Investigate the Safety and Tolerability of TC-5214 Following Oral Administration of Multiple Doses for up to 8 Days [Completed]

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder [Completed]

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder [Completed]

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder. [Completed]

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder. [Terminated]

Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017